Pain treatment with Dr Allen’s Device is proven in people with low back pain, chronic prostatitis and kidney stones

* New clinical trials have confirmed that Thermobalancing therapy with Dr Allen’s Device is the first natural treatment option for effectively relieving chronic pain caused by different health conditions.* Dr Allen’s Device is proven to treat lower bac…

* New clinical trials have confirmed that Thermobalancing therapy with Dr Allen’s Device is the first natural treatment option for effectively relieving chronic pain caused by different health conditions.

* Dr Allen’s Device is proven to treat lower back pain, as well as pain in the inflamed prostate gland, and pain due to kidney stones, by improving blood circulation locally with its non-invasive topical application.

OXFORD, UK / ACCESSWIRE / January 24, 2024 / New clinical studies confirm high efficacy and total safety of Thermobalancing therapy and wearable Dr Allen’s Device in providing pain relief in patients with different ailments, including low back pain, kidney stone disease, and chronic prostatitis or chronic pelvic pain syndrome (CP/CPPS).

"Fine Treatment has completed several clinical trials involving our unique Dr Allen’s Device for treating chronic low back pain, kidney stones, and chronic prostatitis," says the co-founder of Fine Treatment Ariana Adjani. "In all of these clinical studies, Thermobalancing therapy has been used in patients as a monotherapy without other medical interventions. Patient data confirming phenomenal efficacy of Dr Allen’s Device has been published in leading medical journals, and I have shared the data at several international conferences. We’re proud to report major improvements in patient health."

The World Journal of Orthopedics has published the details of a new clinical trial showing successful treatment outcomes with Dr Allen’s Device in men and women with low back pain in the article titled Efficacy and safety of thermobalancing therapy with Dr Allen’s Device for chronic low back pain: A randomised controlled trial.

Successful kidney stone treatment outcomes without renal colic while using Dr Allen’s Device are published in The Archives of Nephrology and Urology journal in the article titled Thermobalancing therapy with Dr Allen’s Device dissolves kidney stones improving health-related quality of life measured by the Wisconsin Stone Quality of Life questionnaire (WISQOL) – a randomised clinical trial.

The International Journal of Quality Innovation reveals the essence of effective chronic prostatitis treatment with Dr Allen’s Device in the article titled Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively.

Significant pain relief in almost all patients and the major improvement in their quality of life have been evident in all clinical studies on Dr Allen’s Device independently conducted by different medical teams. The absence of undesirable side effects evident with the use of Thermobalancing therapy and Dr Allen’s Device, that cannot be achieved with standard treatments, is also a remarkable feature of this non-invasive treatment option.

Standard low back pain treatments

Opioid addiction and overdose in people with chronic low back pain have skyrocketed, becoming a full-fledged public health emergency. Additionally, opioid medications cause constipation, nausea, itching, dizziness, and other unpleasant symptoms.

Alternatives to opioid pain medications include nonsteroidal anti-inflammatory drugs, acetaminophen, anticonvulsants, and others, all of which cause side effects and may cause health problems unrelated to back pain, such as gastrointestinal and cardiovascular diseases.

Standard chronic prostatitis treatments

All drugs for CP/CPPS are found to be causing other nasty health problems:

– α1-blockers group are associated with adverse reactions, postural hypotension, dizziness, asthenia, abnormal ejaculation, and intraoperative floppy iris syndrome;

– 5α-reductase inhibitors (5-ARIs) decrease libido and cause gynecomastia, erectile dysfunction and sexual side effects.

Leading urological associations prohibit all types of surgical interventions on the prostate gland in men with chronic prostatitis due to poor outcomes and awful side effects.

Standard surgical options for kidney stone treatment

Even though the extracorporeal shock wave lithotripsy (ESWL) is considered as a non-invasive therapy, it is still in essence a surgical intervention as aims to break stones in kidneys. While breaking the stones, ESWL can damage the delicate kidney tissue and also, in some cases, the tissues of adjacent organs, such as pancreas or spleen.

Other treatments for kidney stones are percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS). Unfortunately, these surgical procedures are often accompanied by serious complications in men and women.

Non-invasive Allen’s Device as a unique treatment option for chronic pain and diseases

The USPTO-patented Thermobalancing therapy with Dr Allen’s Device is the world’s first treatment that harnesses the body’s own heat while naturally treating chronic pain and the associated health conditions.

Made in England, Fine Treatment’s wearable Dr Allen’s Device can be used at home to treat and prevent pain caused by a variety of health conditions, including low back pain, chronic prostatitis, and kidney stone disease.

Contact Information:

Alex Day
Customer Service Manager
Fine Treatment, Oxford, United Kingdom
Tel.: +447958878300
Email: info@finetreatment.com
www.finetreatment.com

SOURCE: Fine Treatment

View the original press release on accesswire.com

Previous Article

Atlantic Power & Infrastructure Revolutionizes Forestry Practices with Nature Soak Partnership in Hungary

Next Article

Blackwolf Announces DTC Eligibility and Approval to Trade on the OTCQB

Related Posts

IRBT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages iRobot Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important May 7 Deadline in Securities Class Action – IRBT

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between August 5, 2022 and January 26, 2024, both dates inclusive (the “Class Period”), of the important May 7, 2024 lead plaintiff deadline. SO WHAT: If you purchased iRobot securities during the […]

‫تنضم FarEye إلى Microsoft Cloud لنظام البيع بالتجزئة لتعزيز تجربة التجارة الشاملة

شيكاغو، 13 كانون الثاني (يناير) 2022 /PRNewswire/ – ، FarEyeأعلنت اليوم، منصة SaaS العالمية التي تحولت الميل الأخير، عن اختيارها من قبل مايكروسوفت كشريك توسيع في Microsoft Cloud لنظام البيع بالتجزئة. يعمل ذاك التعاون على تمكين وتحويل كيفية قيام تجار التجزئة بتنسيق وتتبع وتحسين حركة البضائع، مما يمكّن المؤسسات من خفض تكاليف الخدمات اللوجستية مع تلبية احتياجات […]

FTX Exchange FZE Receives Dubai’s First Virtual Asset Service Provider MVP Licence from the Virtual Assets Regulatory Authority

DUBAI, United Arab Emirates, July 29, 2022 /PRNewswire/ — FTX Exchange FZE, today announced that it has received approval to enter Dubai’s ‘Minimum Viable Product’ (MVP) programme for Virtual Assets under the world’s only specialist regime for this sector operated by the Virtual Asset Regulatory Authority (VARA). As a subsidiary of FTX Europe, FTX Exchange […]